411 related articles for article (PubMed ID: 28817465)
1. New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension.
Mullin CJ; Mathai SC
Curr Opin Rheumatol; 2017 Nov; 29(6):561-567. PubMed ID: 28817465
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in scleroderma-associated pulmonary hypertension.
Highland KB
Curr Opin Rheumatol; 2014 Nov; 26(6):637-45. PubMed ID: 25203120
[TBL] [Abstract][Full Text] [Related]
3. Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?
Khan SL; Mathai SC
Curr Opin Pulm Med; 2023 Sep; 29(5):380-390. PubMed ID: 37461869
[TBL] [Abstract][Full Text] [Related]
4. An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature.
Sundaram SM; Chung L
Curr Rheumatol Rep; 2018 Feb; 20(2):10. PubMed ID: 29488016
[TBL] [Abstract][Full Text] [Related]
5. Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).
Sobanski V; Launay D; Hachulla E; Humbert M
Curr Rheumatol Rep; 2016 Feb; 18(2):10. PubMed ID: 26841964
[TBL] [Abstract][Full Text] [Related]
6. Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease management.
Hachulla E; Denton CP
Eur Respir Rev; 2010 Dec; 19(118):314-20. PubMed ID: 21119190
[TBL] [Abstract][Full Text] [Related]
7. [Management of borderline pulmonary arterial hypertension associated with connective tissue diseases].
Yoshifuji H; Kinoshita H
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):454-61. PubMed ID: 25748129
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis.
McLaughlin V; Humbert M; Coghlan G; Nash P; Steen V
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii25-31. PubMed ID: 19487219
[TBL] [Abstract][Full Text] [Related]
9. Screening for pulmonary arterial hypertension in patients with scleroderma--a New Zealand perspective.
Ghosh SK; Corkill MM; Hart HH; Ng KP
N Z Med J; 2014 Aug; 127(1400):30-8. PubMed ID: 25145365
[TBL] [Abstract][Full Text] [Related]
10. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.
Thakkar V; Nikpour M; Stevens WM; Proudman SM
Intern Med J; 2015 Mar; 45(3):248-54. PubMed ID: 25735576
[TBL] [Abstract][Full Text] [Related]
11. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
Menon N; McAlpine L; Peacock AJ; Madhok R
Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
[TBL] [Abstract][Full Text] [Related]
12. Worsening gradient of aortic stenosis with treatment of pulmonary arterial hypertension in scleroderma.
Pietras DA; Lopez FR; Peréz R; López-Candales A; Elwing J
Bol Asoc Med P R; 2015; 107(1):41-4. PubMed ID: 26035984
[TBL] [Abstract][Full Text] [Related]
13. Update in systemic sclerosis-associated pulmonary arterial hypertension.
Gashouta MA; Humbert M; Hassoun PM
Presse Med; 2014 Oct; 43(10 Pt 2):e293-304. PubMed ID: 25179278
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets.
Dimitroulas T; Giannakoulas G; Karvounis H; Settas L; Kitas GD
Curr Pharm Des; 2012; 18(11):1457-64. PubMed ID: 22364130
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review.
Bazan IS; Mensah KA; Rudkovskaia AA; Adonteng-Boateng PK; Herzog EL; Buckley L; Fares WH
Respir Med; 2018 Jan; 134():42-46. PubMed ID: 29413506
[TBL] [Abstract][Full Text] [Related]
16. Therapy for pulmonary arterial hypertension associated with systemic sclerosis.
Mathai SC; Hassoun PM
Curr Opin Rheumatol; 2009 Nov; 21(6):642-8. PubMed ID: 19667994
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment.
Attanasio U; Cuomo A; Pirozzi F; Loffredo S; Abete P; Petretta M; Marone G; Bonaduce D; De Paulis A; Rossi FW; Tocchetti CG; Mercurio V
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580360
[TBL] [Abstract][Full Text] [Related]
18. Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol.
Calderone A; Stevens W; Prior D; Nandurkar H; Gabbay E; Proudman SM; Williams T; Celermajer D; Sahhar J; Wong PK; Thakkar V; Dwyer N; Wrobel J; Chin W; Liew D; Staples M; Buchbinder R; Nikpour M
BMJ Open; 2016 Dec; 6(12):e011028. PubMed ID: 27932335
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of pulmonary hypertension in systemic sclerosis.
Sweiss NJ; Hushaw L; Thenappan T; Sawaqed R; Machado RF; Patel AR; Gomberg-Maitland M; Husain AN; Archer SL
Curr Rheumatol Rep; 2010 Feb; 12(1):8-18. PubMed ID: 20425528
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis-associated pulmonary arterial hypertension.
Le Pavec J; Humbert M; Mouthon L; Hassoun PM
Am J Respir Crit Care Med; 2010 Jun; 181(12):1285-93. PubMed ID: 20194816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
